123 Main Street, New York, NY 10001
Meet Primer Ai, the Co-Dx AI platform where data, insight, and discovery drive continuous intelligence—advancing the future of diagnostics.
AI opens new possibilities for turning complex diagnostic data into meaningful insights—revealing patterns, trends, and connections that help drive understanding across populations and time.
As AI advances, diagnostics will evolve from static measurements to adaptive intelligence—informing where and how resources are deployed to make testing more responsive and efficient.
Future AI systems will help unify diagnostic data across locations, test types, and devices—paving the way for greater consistency, interoperability, and real-time collaboration.
AI-driven models will someday predict shifts in disease dynamics, supporting earlier responses and helping laboratories, clinicians, and health systems stay ahead.
Pinpoints stable and relevant targets by scanning vast genomic datasets, comparing conservation, mutation rates, and cross-reactivity.
Analyzes reagent chemistries, consumable designs, and instrument tolerances to optimize system components and ensure consistent, reliable PCR performance at scale.
Learns from amplification and melt curve data to sharpen result calling and to improve test accuracy.
Co-Diagnostics, Inc.
2401 S. Foothill Dr. Suite D
Salt Lake City, UT 84109 USA
1 (801) 438-1036
info@co-dx.com
Co-Dx, Co-Primers, Logix Smart, Co-Dx Box, PCR Home, PCR Pro, and Vector Smart, and unless otherwise specified, all other product and service names appearing in this Internet site are trademarks owned by Co-Diagnostics, Inc., its subsidiaries or affiliates. No use of any Co-Diagnostic trademark, trade name, or trade dress in this site may be made without the prior written authorization of Co-Diagnostics, except to identify the product or services of the company.
TaqMan is a trademark of Roche Molecular Systems.